Max Robotics — Global Service Robot Directory + US Certification

About

Gerald Zeng is a pioneering surgeon and researcher whose work centers on advancing minimally invasive techniques in hepatopancreatobiliary surgery, with a particular focus on gallbladder cancer and pancreato-biliary procedures. His major contributions include challenging traditional surgical dogmas by demonstrating the feasibility and safety of minimally invasive surgery (MIS) for suspected gallbladder cancer, a field where open surgery had long been the standard. In his landmark 2018 study (18 citations), Zeng provided crucial evidence that MIS could yield favorable short-term outcomes for these complex patients, helping to shift clinical practice toward less invasive approaches. He further solidified his impact through a 2020 study (14 citations) examining the adoption of minimally-invasive pancreato-biliary surgery in Southeast Asia, where he documented changing trends and outcomes as an early adopter in the region. This work has been particularly valuable for surgeons in resource-limited settings seeking to implement advanced MIS programs. Zeng’s research, though early in its citation trajectory, represents foundational evidence for the safe expansion of minimally invasive approaches in challenging oncologic contexts, establishing him as an influential voice in the global conversation on surgical innovation.